PEG-PLA copolymer nanoparticles physically loaded with docetaxel (drug loading around 10%) with a targeting small-molecule ligand specific for PSMA. Size around 100 nm.Note: BIND-014 is the first-in-man targeted and controlled-release nanoparticles for cancer therapy. This evidence concerns the gene FOLH1 and cancer.